Compound Report Overview
Compound Name:
SB-203580
Compound Identifier:
704681
Mol Structure 2D:
704681
Molecular Weight:
377
Formula:
C21 H16 F N3 O S
Development Status:
Preclinical
SMILES:
CS(=O)c1ccc(cc1)c2nc(c([nH]2)c3ccc(F)cc3)c4ccncc4
Compound Activites
| Compound | Assay | Assay Name | View |
|---|---|---|---|
| SB-203580 | 641 | CYP450-2C19 Inhibition | View |
| SB-203580 | 79 | Adenosine Transporter | View |
| SB-203580 | 167 | Muscarinic M1 | View |
| SB-203580 | 640 | CYP450-1A2 Inhibition | View |
| SB-203580 | 76 | Adenosine A2A | View |
| SB-203580 | 208 | Serotonin 5-HT4 | View |
| SB-203580 | 643 | CYP450-2D6 Inhibition | View |
| SB-203580 | 42 | Phosphodiesterase PDE4 | View |
| SB-203580 | 635 | Protein Tyrosine Kinase, Fyn | View |
| SB-203580 | 82 | Adrenergic alpha1D | View |
| SB-203580 | 57 | Protein Serine/Threonine Kinase, ERK1 | View |
| SB-203580 | 63 | Protein Serine/Threonine Kinase PKCalpha | View |
| SB-203580 | 628 | Melanocortin MC5 | View |
| SB-203580 | 634 | Protein Tyrosine Kinase, EGF Receptor | View |
| SB-203580 | 639 | Thromboxane Synthetase | View |
| SB-203580 | 75 | Adenosine A1 | View |
| SB-203580 | 642 | CYP450-2C9 Inhibition | View |
| SB-203580 | 636 | Protein Tyrosine Kinase, Lck | View |
| SB-203580 | 632 | Protein Serine/Threonine Kinase, p38alpha | View |
| SB-203580 | 193 | Progesterone | View |
| SB-203580 | 33 | Monoamine Oxidase MAOA | View |
| SB-203580 | 102 | Calcium Channel Type L, Dihydropyridine | View |
| SB-203580 | 183 | Opiate mu | View |
| SB-203580 | 43 | Phosphodiesterase PDE5 | View |
| SB-203580 | 59 | Protein Tyrosine Kinase, HER2 Receptor | View |